Last Updated: November 13, 2026

Details for Patent: 8,933,097

Name: Drug Patent Intelligence for US Patent 8933097
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 8,933,097 protect, and when does it expire?

Patent 8,933,097 protects CHILDREN'S ALLEGRA ALLERGY and CHILDREN'S ALLEGRA HIVES and is included in one NDA.

This patent has forty-three patent family members in thirty-eight countries.

Summary for Patent: 8,933,097

Title:	Fexofenadine suspension formulation
Abstract:	The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
Inventor(s):	Kazimierz CHRZAN, Rajiv HARIBHAKTI, Matthew MERMEY, Curtis J. PORCELLO, Gary Lee Silvey, Vinh Tran, Prafulla Agrawala
Assignee:	Chattem Inc
Application Number:	US12/138,468
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 8,933,097

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chattem Sanofi	CHILDREN'S ALLEGRA ALLERGY	fexofenadine hydrochloride	SUSPENSION;ORAL	201373-001	Jan 24, 2011		OTC	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y				⤷ Start Trial
Chattem Sanofi	CHILDREN'S ALLEGRA HIVES	fexofenadine hydrochloride	SUSPENSION;ORAL	201373-002	Jan 24, 2011		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial	Y				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,933,097

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	058323	⤷ Start Trial
Austria	E431137	⤷ Start Trial
Australia	2006326551	⤷ Start Trial
Brazil	PI0619895	⤷ Start Trial
Canada	2633086	⤷ Start Trial
China	101316580	⤷ Start Trial
Costa Rica	9993	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.